Table 2 KIR gene frequencies among patients with lung cancer and healthy controls.

From: KIR-HLA gene diversities and susceptibility to lung cancer

KIR genes

Healthy controls

Lung cancer

Comparisons

Lung cancer

NSCLC

SCLC

Lung cancer versus HC

NSCLC versus HC

SCLC versus HC

n = 448

n = 232

n = 179

n = 53

p value

OR (95% CI)

p value

OR (95% CI)

p value

OR (95% CI)

%F (N + /n)

%F (N + /n)

%F (N + /n)

%F (N + /n)

Group-A haplotype-associated KIR genes

2DL1

98.0 (439/448)

97.4 (226/232)

97.2 (174/179)

98.1 (52/53)

      

2DL3

88.2 (395/448)

85.3 (198/232)

84.4 (151/179)

88.6 (47/53)

      

3DL1

92.6 (415/448)

95.3 (221/232)

96.6 (173/179)

92.4 (49/53)

      

2DS4

92.9 (416/448)

94.8 (220/232)

95.5 (171/179)

92.4 (49/53)

      

2DS4fl

12.9 (31/242)

10.4 (18/174)

10.2 (14/137)

10.8 (4/37)

      

2DS4del

73.5 (178/242)

70.6 (123/174)

70.8 (97/137)

70.3 (26/37)

      

2DS4fl,del

13.6 (33/242)

19.0 (33/174)

19.0 (26/137)

18.9 (7/37)

      

Group-B haplotype-associated KIR genes

2DL2

55.4 (248/448)

67.2 (156/232)

65.9 (118/179)

71.6 (38/53)

0.003

1.63 (1.17–2.26)

0.016

1.56 (1.087–2.24)

0.027

2.04 (1.09–3.82)

2DL5

66.1 (296/448)

63.8 (148/232)

64.2 (115/179)

62.2 (33/53)

      

3DS1

47.3 (212/448)

37.5 (87/232)

36.8 (66/179)

39.6 (21/53)

0.015

0.67 (0.48–0.92)

0.02

0.65 (0.43–0.93)

  

2DS1

50.2 (225/448)

41.4 (96/232)

41.3 (74/179)

41.5 (22/53)

0.029

0.69 (0.5–0.95)

    

2DS2

54.5 (244/448)

62.9 (146/232)

62.0 (111/179)

66.0 (35/53)

0.041

1.42 (1.02–1.96)

    

2DS3

41.5 (186/448)

40.1 (93/232)

39.6 (71/179)

41.5 (22/53)

      

2DS5

39.5 (177/448)

32.8 (76/232)

32.9 (59/179)

32.0 (17/53)

      

Framework genes/pseudogenes

2DL4

100 (448)

100 (232)

100 (179)

100 (53)

      

3DL2

100 (448)

100 (232)

100 (179)

100 (53)

      

3DL3

100 (448)

100 (232)

100 (179)

100 (53)

      

2DP1

97.8 (438)

96.1 (223)

94.9 (170)

100 (53)

      

3DP1

100 (448)

100 (232)

100 (179)

100 (53)

      
  1. N+ number of individuals positive for the gene, n number of individuals tested for the gene, HC healthy control, OR odds ratio, CI confidence interval. p < 0.05: statistically significant; based on two-tailed Fisher’s exact test.